Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging
Background & aims: Terlipressin improves renal function in ∼40% of patients with hepatorenal syndrome–acute kidney injury (HRS-AKI). Nonetheless, the pathophysiological mechanisms of terlipressin remain unclear. Therefore, we investigated the cardiovascular changes that occur after terlipres...
Saved in:
| Main Authors: | Karen Vagner Danielsen, Jens Dahlgaard Hove, Puria Nabilou, Thit Mynster Kronborg, Signe Wiese, Hartwig Roman Siebner, Robert Scott, Susan T. Francis, Guruprasad P. Aithal, Søren Møller, Flemming Bendtsen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | JHEP Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555925001302 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease
by: Xia Wan, et al.
Published: (2025-04-01) -
Terlipressin in the treatment of neonatal refractory hypotension caused by septic shock: a case report
by: Quanyao Chen, et al.
Published: (2020-08-01) -
Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trial
by: Valeria Perez-Campuzano, et al.
Published: (2025-04-01) -
Efficacy of low doses of terlipressin to prevent intra-operative blood loss in obstetrics
by: Yu. S. Аleksandrovich, et al.
Published: (2020-09-01) -
Terlipressin at esophageal varicose bleeding at liver cirrhosis with portal hypertension syndrome
by: B. N. Kotiv, et al.
Published: (2013-10-01)